tiprankstipranks
Positive Buy Rating for Scholar Rock Holding Driven by Promising Developments and Milestones in Apitegromab’s Approval Process
PremiumRatingsPositive Buy Rating for Scholar Rock Holding Driven by Promising Developments and Milestones in Apitegromab’s Approval Process
26d ago
Scholar Rock Holding’s Promising Advances with Apitegromab Drive Buy Rating
Premium
Ratings
Scholar Rock Holding’s Promising Advances with Apitegromab Drive Buy Rating
26d ago
Scholar Rock Reports 2024 Financial Results and Progress
Premium
Company Announcements
Scholar Rock Reports 2024 Financial Results and Progress
26d ago
Scholar Rock submits apitegromab BLA to FDA
PremiumThe FlyScholar Rock submits apitegromab BLA to FDA
2M ago
Scholar Rock submits apitegromab BLA to FDA
Premium
The Fly
Scholar Rock submits apitegromab BLA to FDA
2M ago
Scholar Rock Highlights Apitegromab Progress at JP Morgan
Premium
Company Announcements
Scholar Rock Highlights Apitegromab Progress at JP Morgan
2M ago
Biohaven outcome ‘fundamental net positive’ for Scholar Rock, says JPMorgan
PremiumThe FlyBiohaven outcome ‘fundamental net positive’ for Scholar Rock, says JPMorgan
4M ago
Truist ups Scholar Rock targets, calls potential takeout target
Premium
The Fly
Truist ups Scholar Rock targets, calls potential takeout target
4M ago
Scholar Rock ‘easier to own’ after Biohaven data, says Jefferies
Premium
The Fly
Scholar Rock ‘easier to own’ after Biohaven data, says Jefferies
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100